Epredia

What Epredia does

Epredia is a precision cancer diagnostics company that provides a comprehensive portfolio of histology instrumentation, consumables, digital pathology solutions, immunohistochemistry (IHC) products, and cytology equipment to clinical pathology laboratories, research institutions, and pharmaceutical companies globally. Established in July 2019 through PHC Holdings Corporation's acquisition of Thermo Fisher Scientific's Anatomical Pathology business, the company builds on heritage brands including Shandon, Microm, Menzel Gläser, and Richard-Allan Scientific, with operational roots dating to 1937. The company reports products are used 48 times every second and over one billion customer touchpoints per year across its installed base.

The product portfolio spans the full anatomical pathology workflow. Capital equipment includes tissue processors, embedders, microtomes, cryostats, stainers, coverslippers, and slide/cassette printers. The SlideMate Laser (600 dpi laser printing, enabling 50 characters per barcode vs. 23 with conventional technology) and SlideMate Thermal Slide Printer are flagship products for sample traceability. Digital pathology is anchored by the FDA 510(k) cleared E1000 Dx whole-slide imaging scanner, capable of processing up to 1,500 tissue samples daily, complemented by the QuantCenter image analysis software platform and ClearVue coverslipper. AI image analysis is integrated through distribution partnerships with Mindpeak, Aiforia, and Paige, delivering pixel-level cancer diagnostics for breast, lung, and gastrointestinal pathology. Recurring revenue is driven by histology consumables including reagents, paraffin, microscope slides, blades, cassettes, biopsy bags, H&E and special stains, and archiving supplies.

Epredia employs a hybrid go-to-market combining direct enterprise field sales with regional customer care centers in the US (Portsmouth, NH; Kalamazoo, MI), UK (Runcorn), Germany (Dreieich), Italy (Milan), and Benelux, complemented by channel partners for AI solutions and a factory store for excess inventory. Manufacturing is distributed across the US, France (Lyon, via acquired MMFrance and Laurypath), and Italy (San Benedetto del Tronto), with engineering/R&D presence in the UK (Shandon Diagnostics) and Hungary (Pathology Innovation Incubator joint venture with 3DHISTECH). The company is a wholly-owned subsidiary of PHC Holdings Corporation (TSE: 6523), a publicly traded Japanese healthcare conglomerate that received TSE listing approval in October 2021.

Name

Epredia

Legal name

Epredia

Website

https://epredia.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Epredia is a precision cancer diagnostics company providing histology instrumentation, consumables, digital pathology scanners, immunohistochemistry products, and cytology equipment to clinical pathology laboratories, academic research institutions, and pharmaceutical companies worldwide.

Ownership category

akta.pro rank

Product category

Anatomical Pathology Diagnostics

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics) (HLAHAAAE)

akta.pro secondary industries

Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG), Anatomic Pathology & Histopathology (Trial Support) (HLAGAEAC), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• Anatomical pathology
• Histology instrumentation
• Digital pathology
• Whole slide imaging
• Cancer diagnostics

Headquarters

HQ city

Kalamazoo

HQ country

United States

HQ region

North America

Offices12 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Histology Instrumentation Sales: Sale of capital equipment including tissue processors, embedders, microtomes, cryostats, stainers, coverslippers, and slide/cassette printers to pathology laboratories. One-time capital purchase model with recurring service and support contracts.
2. Histology Consumables: Recurring revenue from consumable products including reagents, paraffin, microscope slides, blades, cassettes, biopsy bags, coverglass, mounting media, frozen media, H&E and special stains, prefills, and archiving supplies.
3. Digital Pathology Solutions: Whole-slide imaging scanners (Dx and Rx), tissue microarrayers, image analysis software, image management software, and digital pathology accessories. Capital equipment sales with software licensing and support.
4. Immunohistochemistry Products: IHC instruments, primary antibodies, detection kits, and ancillaries for diagnostic and research use on flexible open platforms.
5. Cytology Products: Cytospin instruments, Cytofunnels, Cytoslides, and reagents and stains for cytology applications.
6. Distribution Partnership Revenue: Revenue from distribution partnerships including global distribution rights for Aiforia, Paige, and Mindpeak AI pathology solutions, expanding the product portfolio without direct R&D investment.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels9 records

Core offering

Epredia manufactures and distributes precision cancer diagnostics products for anatomical pathology laboratories worldwide. Its core offerings span histology instrumentation (tissue processors, embedders, microtomes, cryostats, stainers, slide/cassette printers), histology consumables (reagents, paraffin, microscope slides, blades, cassettes, stains), digital pathology whole-slide imaging scanners and image management/analysis software, immunohistochemistry (IHC) instruments and reagents, and cytology products.

Differentiator

Problem solved

Functional benefit

Brands

• SlideMate: Slide printing instruments including SlideMate Laser and SlideMate Thermal Slide Printer for pathology laboratories
• E1000 Dx
• Revos
• NOVA
• VEGA
• QuantCenter
• ClearVue
• Cytospin

Products and services

• E1000 Dx Digital Pathology Solution High-speed, automated whole-slide imaging scanner for clinical cancer diagnostics, producing high-resolution digital images of up to 1,500 tissue samples daily to reduce turnaround times and improve pathologist productivity. FDA 510(k) cleared.
• SlideMate Thermal Slide Printer Thermal transfer printing system for pathology laboratories designed to produce permanent labels on microscope slides, with enclosed slide hoppers to protect samples from dust contamination. Engineered for integration into histology, cytology, and other pathology workflows.
• SlideMate Laser Printer 600 dpi high-resolution laser printing technology for microscope slides, enabling up to 50 characters in a barcode per slide compared to 23 characters in conventional thermal transfer and inkjet technologies, with LIS connectivity for workflow integration.
• NOVA and VEGA Laser Cassette Printers 600 dpi laser cassette printers enabling up to 100 characters per cassette compared to 50 characters in older thermal transfer and inkjet technologies, improving sample tracking throughout the diagnostic workflow.
• Histology Instrumentation Portfolio Capital equipment including tissue processors, embedders, microtomes, cryostats, stainers, coverslippers, and slide/cassette printers for pathology laboratories.
• Histology Consumables Recurring consumable products including reagents, paraffin, microscope slides, blades, cassettes, biopsy bags, coverglass, mounting media, frozen media, H&E and special stains, prefills, and archiving supplies for histology laboratories.
• Immunohistochemistry (IHC) Products IHC instruments, primary antibodies, detection kits, and ancillaries for diagnostic and research use on flexible open platforms.
• Cytology Products Cytospin instruments, Cytofunnels, Cytoslides, and reagents and stains for cytology applications.
• Digital Pathology Whole Slide Imaging and Image Management Software Whole-slide imaging scanners (Dx and Rx), tissue microarrayers, image analysis software, image management software, and digital pathology accessories sold as digital pathology solutions with software licensing and support.
• 3DHISTECH P1000 WSI Scanner Commercial partnership for digital slide-scanning technology, distributing the 3DHISTECH P1000 WSI Scanner as part of Epredia's digital pathology portfolio.

Quantifiable outcome

• E1000 Dx processes up to 1,500 tissue samples daily
• +4 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability3 records

Feature6 records

Partnerships

Five partnerships are on record, tiered core and minor.

• MindpeakcoreChannel Partner/ Reseller/ Distributor · 24 February 2026EU distribution agreement for Mindpeak's AI-powered image recognition software. Provides pixel-level analysis of digital tissue images for breast cancer, lung cancer, and gastrointestinal pathology diagnostics. Designed to reduce variability and improve workflow efficiency for pathology laboratories. Integration planned into Epredia's E1000 Dx digital pathology workflow for seamless image interpretation and data exchange.
• 3DHISTECHcoreStrategic or Co-development Partner · 23 March 2023Joint venture for Pathology Innovation Incubator in Budapest, Hungary. Commercial partners in digital slide-scanning technology. Both companies financially support and contribute knowledge transfer and technology exchange to develop solutions for faster and more accurate cancer diagnosis. Opened March 2023 with support from Hungarian Ministry of Foreign Affairs and Trade.
• RegenMed Hub Innovation AcceleratorminorStrategic or Co-development Partner · 18 January 2023PHC Group and Epredia joined the RegeneratOR Innovation Accelerator in Winston-Salem, North Carolina. Focus on regenerative medicine with local office established. Epredia serves as global distribution partner for Aiforia's preclinical and clinical pathology tools within this ecosystem.
• AiforiacoreChannel Partner/ Reseller/ Distributor · 21 June 2021Global distribution partnership for Aiforia's portfolio of workflow-improving solutions using deep learning AI for image analysis in pathology. Epredia has segment exclusivity for distribution in Japan, Germany, UK, Italy, Spain, Sweden, Norway, Denmark, Iceland, France, and USA. Also led Aiforia's Series B funding round (€12.6M initial tranche, potentially €25.2M with second tranche).
• PaigecoreChannel Partner/ Reseller/ Distributor · 17 March 2021Global distribution agreement for Paige's portfolio of AI-based diagnostic software solutions for pathology. Epredia has exclusive distribution rights in Japan. Marketing began Q2 2021 in US and major European countries alongside existing Epredia products.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Hologic: Hologic's cytology and diagnostics business, including the ThinPrep system, competes directly with Epredia's Cytospin cytology product line and broader cytology reagents and stains portfolio.
• Danaher (Leica Biosystems): Leica Biosystems is a leading manufacturer of histology instruments, consumables and digital pathology solutions, directly competing with Epredia across the anatomical pathology workflow including tissue processors, stainers, microtomes and whole-slide imaging scanners.
• Sakura Finetek: Sakura Finetek manufactures tissue processors, embedding systems, microtomes and histology consumables, directly competing with Epredia's histology instrumentation and consumables offerings across hospital and independent labs.
• Hamamatsu Photonics: Hamamatsu is a leading manufacturer of whole-slide imaging scanners and digital pathology systems, directly competing with Epredia's E1000 Dx Digital Pathology Solution and broader digital pathology portfolio.
• 3DHISTECH: 3DHISTECH manufactures digital slide scanners and pathology workflow solutions, both as a commercial partner of Epredia (P1000 WSI Scanner distribution, Budapest JV) and a direct competitor in the digital pathology market.
• Roche (Ventana Medical Systems): Roche's Ventana division is a major competitor in anatomic pathology, offering automated staining systems, IHC instruments, primary antibodies and digital pathology solutions that directly overlap with Epredia's histology, IHC and digital pathology portfolios.

Broad incumbents

• Agilent Technologies: Agilent's pathology and IHC portfolio, including Dako reagents and primary antibodies, competes with Epredia's immunohistochemistry products and overlaps in the broader life science tools and diagnostics market.
• Philips (Digital Pathology): Philips' IntelliSite Digital Pathology Solution competes with Epredia's E1000 Dx in clinical whole-slide imaging, with Philips leveraging a broader healthcare IT portfolio and larger installed base across integrated hospital systems.

Emerging players

• Paige.AI: Paige develops AI-based diagnostic software for pathology with which Epredia has a global distribution agreement; Paige is both a partner and emerging competitive threat as it builds direct relationships with health systems for AI-native pathology.
• Aiforia: Aiforia provides deep-learning AI image analysis tools for clinical and preclinical pathology, partnered with Epredia for distribution globally. Aiforia is both a channel partner and an emerging competitor as it pursues CE-IVD-marked clinical tools in breast and lung cancer diagnostics.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/Epredia_dx
• LinkedInlinkedin.com/company/epredia

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Epredia